期刊文献+

传染病医院检验科生物安全管理及防护措施探讨 被引量:4

To Explore Biological Safety Management and Protective Measures in Clinical Laboratory of the Infectious Disease Hospital
原文传递
导出
摘要 目的:探讨传染病医院检验科生物安全管理及防护措施。方法:对传染病医院检验科实验室相关人员的职责进行明确分工,使其进一步了解实验室生物操作风险的种类及来源,并在实验室配备必要的安全防护措施,对标本施行严格的管理制度。结果:严格施行检验科实验室生物安全管理,增加防护措施,可以有效的避免生物安全事故的发生。结论:对检验科实验室生物安全管理进行规范后可以有效地减少实验室工作人员的风险,同时也有效避免了病源微生物的外泄,最大限度的保障了实验室的生物安全。 Objective: To study biological safety managements and protective measures in clinical laboratory of the infectious diseases hospital. Methods: To clearly define the related personnel division of responsibilities in the clinical laboratory of infectious diseases hospital. At the same time, to make its further understand for biological laboratory operational risk types and sources, and the necessary safety protection and the specimen of strict management system were equipped in the laboratory. Results: The strict enforcement of bio- logical laboratory safety management, increasing the protection measures, can effectively avoid biological safety accidents. Conclusion: The standard biosafety laboratory management in clinical laboratory can effectively reduce the risk of lab staff, meanwhile effectively avoid the pathogenic microbes leaked, and guarantee maximally biological safety in the lab.
机构地区 解放军第
出处 《现代生物医学进展》 CAS 2013年第7期1364-1366,共3页 Progress in Modern Biomedicine
基金 国家科技重大专项"十二五"课题<中医药防治病毒性肝炎的临床科研基地建设>2012zx10005010-002-002
关键词 传染病 医院检验科 生物安全管理 防护措施 Infectious diseases Hospital clinical laboratory Biological safety management Protective measures
  • 相关文献

参考文献21

  • 1Silva DN, Rochedo ER, Wasserman MA, et al. Evaluation of protec-tive measures for tropical environments [J]. Radiat Prot Dosimetry,2012,151(4):696-700.
  • 2Peters E, Kunreuther H, Sagara N, et al. Protective Measures, PersonalExperience, and the Affective Psychology of Time [J]. Risk Anal,2012,doi: 10.1111/j.l539-6924.2012.01810.x.
  • 3Sanada S, Komuro I,Kitakaze M. Pathophysiology of myocardialreperfusion injury: preconditioning, postconditioning, and translationalaspects of protective measures [J]. Am J Physiol Heart Circ Physiol,2011,301(5):H1723-1741.
  • 4Gautret P, Vu Hai V,Sani S, et al. Protective measures against acuterespiratory symptoms in French pilgrims participating in the Hajj of2009 [J]. J Travel Med, 2011,18(1):53-55.
  • 5Brown JR, Thompson CA. Contrast-induced acute kidney injury: theat-risk patient and protective measures [J]. Curr Cardiol Rep,2010,12(5):440-445.
  • 6Baldauf S. Protective measures [J]. US News World Rep, 2008, 144(8):57.
  • 7Kato S, Aoshima H, Saitoh Y, et al. Biological safety of LipoFullerenecomposed of squalane and fiillerene-C60 upon mutagenesis, photocy-totoxicity, and permeability into the human skin tissue [J], Basic ClinPharmacol Toxicol, 2009,104(6):483-487.
  • 8Hall L,Otter JA, Chewins J, et al. Use of hydrogen peroxide vapor fordeactivation of Mycobacterium tuberculosis in a biological safetycabinet and a room [J]. J Clin Microbiol, 2007,45(3):810-815.
  • 9Motsoane NA, Bester MJ, Pretorius E, et al. An in vitro study of bio-logical safety of condoms and their additives [J]. Hum Exp Toxicol,2003,22(12):659-664.
  • 10Wheaton DH, Hoffinan DR, Locke KG, et al. Biological safety as-sessment of docosahexaenoic acid supplementation in a randomizedclinical trial for X-linked retinitis pigmentosa [J]. Arch Ophthalmol,2003,121(9):1269-1278.

同被引文献31

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部